RhythmX AI Welcomes Former HCA Outpatient Health Information Officer Dr. Ed Glynn as Clinical Director

Dr. Glynn will lead and deliver highly trusted clinical innovations with deep experience at the intersection of clinical care, informatics and artificial intelligence

The Clinical Director will develop a hyper-personalized healthcare platform using revolutionary generative artificial intelligence and collaborating with renowned physicians on the RhythmX AI expert panel

PALO ALTO, California., June 11, 2024 /PRNewswire/ — RhythmX AI, a generative artificial intelligence company with a precision care platform for physicians that provides physicians with hyper-personalized care to the right patient at the right time, announced today that Ed GlynnMD, MBA, FAAFP, joined the leadership team as Clinical Director.

As a board-certified family physician and IT specialist, Dr. Glynn has played a key role in enabling the standardization, modernization and optimization of HCA’s ambulatory EHR system, which underpins clinic and practice workflows in more than 1,600 locations and impacts the care of nearly 15 million patients annually.

“Dr. Glynn combines real-world experience with clinical workflows in large health systems, practicing as a family physician and IT professional working across teams and leaders at the largest scale,” said Deepthi Bathina, CEO and founder of RhythmX AI. “Experience at this intersection is a requirement for continuous and complex innovation and the success of a hyper-personalized health care model. Dr. Glynn shares the priority we place on drawing on expert clinical experience and cutting-edge artificial intelligence to achieve a clear and insightful vision of what is required on the front lines of medicine. He is committed to maintaining and expanding our partnerships with leading physicians who today advocate for hyper-personalized care.

“I am excited to join RhythmX AI as its first Chief Clinical Officer at this pivotal time in the healthcare industry,” said Dr. Glynn. “We are witnessing an explosion of artificial intelligence in everyday life, a constant burden on our healthcare workers, and a cry from patients for advanced, personalized care. In my new role, I will seek to bring together the voices of our clinical experts, along with their unique knowledge and expertise, while leveraging the power of artificial intelligence. Our mission is to make healthcare delivery easier and more rewarding for healthcare professionals, while providing patients with more advanced and personalized healthcare.”

Dr. Glynn’s role includes:

  • We are a leader and deliver innovation through the RhythmX AI platform, which is highly trusted by doctors around the world
  • Continue to build and support a distinguished external panel of RhythmX AI clinical experts and internal clinical staff. The RhythmX AI expert panel will play a key role in comprehensive product development at the intersection of artificial intelligence and clinical experience, resulting in a platform that has the hallmarks of leaders in their fields
  • Coordinate clinical and clinical informatics aspects of health-related AI products
  • Improving sustainable and efficient processes for continuous clinical validation of products and models

The RhythmX AI Expert Panel currently consists of recognized healthcare leaders, clinical experts and specialists working with the RhythmX AI team. The current panel contains:

  • Dr. Andrew Albano – DO, MBA, CPE, FAAFP, DABFM. Medical Director – Population Health Management, inVio Health Network, Prisma Health. associate professor, University of South Carolina Medical School – Greenville
  • Dr. Luiza Caramori – medical doctor, MSc, PhD, Department of Endocrinology, Diabetes and Metabolism; Department of Cardiovascular and Metabolic Sciences; Cleveland Clinic
  • Dr. Kenny Cole – MD, VP MS System, Clinical Improvement, Ochsner Health
  • Dr. Sarika K. Desai, DO – Cardiologist, Chief Executive Officer ARYZONA HEART 360. Clinical Professor of Medicine, University of Arizona
  • Dr. Kunihiro Matsushita – MD, PhD Department of Epidemiology: Cardiovascular and Clinical Epidemiology Johns Hopkins Bloomberg School of Public Health
  • Dr. Sankar Navaneethan – MBBS, MPH Asst. Chief Nephrologist / Director of Clinical Research Baylor College of Medicine
  • Dr. Anish Shah – MD, Family Medicine Physician, Froedtert Health
  • Dr. Sri Lekha Tummalapalli – MD, MBA, MAS Department of Population Health Sciences and Division of Nephrology and Hypertension Weill Cornell Medicine

Prior to joining RhythmX AI, Dr. Glynn served as Chief Ambulatory Information Officer for HCA Healthcare, one of the nation’s leading healthcare providers with 188 hospitals and approximately 2,400 ambulatory care sites in 20 U.S. states and United Kingdom.

During his twelve-year tenure, Dr. Glynn managed HIT strategy, implementation, and clinical support for over 1,600 outpatient clinics, GME programs, and urgent care centers. His team of clinicians and IT specialists managed annual implementations for over 1,400 providers and enterprise support for over 13,000 providers across HCA. Dr. Glynn also served as the organization’s CMIO, leading HCA’s physician services to create, maintain, secure and create business-critical clinical information that is reliable and actionable to promote improved outcomes, patient comfort and effective patient health care.

His experience also includes the Bon Secours healthcare system. Dr. Glynn received his M.D. from Eastern Virginia Medical School and his M.B.A. with Belmont University. He has certificates in family medicine and computer science. Dr. Glynn is a Fellow of the American Academy of Family Practice.

About RhythmX AI
RhythmX AI is a generative AI-powered healthcare company driving a paradigm shift in hyper-personalized care. The RhythmX AI precision care platform helps physicians usher in a new era of holistic care with AI-powered generative and predictive co-pilots. RhythmX AI, a SAIGroup company, will leverage the company’s various assets, including its advanced Eureka AI platform and longitudinal data on 300 million patients, more than 4.4 billion in total annual claims, and more than 1.8 million healthcare professionals in more than 300,000 facilities. RhythmX AI is comprised of healthcare and technology experts, operators and industry-leading clinical advisors.

About SAIGrupa
SAIGroup is a private investment firm building leading enterprise AI businesses by accelerating innovation and growth. SAIGroup ConcertAI, SymphonyAI and RhythmX AI companies employ over 4,000 employees. Founder and CEO Dr. Romesh Wadhwani has provided $1 billion in investment capital to SAIGroup.

Contact with the media: (email protected)